Transcriptional pause release at enhancers mediates cell identity
NAR Cancer · 2025
DOI: 10.1093/narcan/zcaf039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NAR Cancer, 2025. Verfasst von Thomas L Ekstrom und 1 weiteren Autor:innen. Beteiligte Einrichtung: Robert Bosch Center for Tumor Diseases, Stuttgart70376,Germany. Hauptthemen laut MEDLINE: Enhancer Elements, Genetic, RNA Polymerase II, Transcription, Genetic, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Robert Bosch Foundation.
Abstract (Originalsprache)
This short review highlights recent findings related to transcription factor-mediated RNA polymerase II (Pol II) pause release at enhancers and its role in regulating cell identity. We discuss how the transcriptional state of Pol II, either paused or released, shapes enhancer–promoter interactions, thereby influencing gene expression programs that define cell identity. We further summarize current knowledge of DNA-binding transcription factors that regulate Pol II pause release at enhancers and explore how this process influences cell identity. We propose a novel concept of therapy-induced molecular amnesia, where temporary inhibition of enhancer-proximal Pol II pause release and enhancer RNA transcription affects enhancer–promoter interactions differently in distinct cellular contexts. In some contexts, preservation of enhancer–promoter interactions allows rapid transcriptional reactivation and maintenance of cell identity upon recovery. In other contexts, repeated inhibition of enhancer RNA transcription leads to the permanent dissociation of enhancer–promoter interactions and loss of cell identity. Our model suggests that manipulating Pol II pause release at enhancers could selectively reverse certain aggressive tumor cell identities, limit tumor cell plasticity, and improve therapy responsiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Robert Bosch Center for Tumor Diseases, Stuttgart70376,Germany.
- Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, United States.
- University of Tübingen, Tübingen, Germany.
ORCID-Profile: Thomas L Ekstrom, Steven A Johnsen
Förderung
- Robert Bosch Foundation
Zitieren
APA
Ekstrom, T. L., & Johnsen, S. A. (2025). Transcriptional pause release at enhancers mediates cell identity. NAR Cancer. https://doi.org/10.1093/narcan/zcaf039
Vancouver
Ekstrom TL, Johnsen SA. Transcriptional pause release at enhancers mediates cell identity. NAR Cancer. 2025. doi:10.1093/narcan/zcaf039
BibTeX
@article{Ekstrom2025,
author = {Ekstrom, Thomas L and Johnsen, Steven A},
title = {Transcriptional pause release at enhancers mediates cell identity},
journal = {NAR Cancer},
year = {2025},
doi = {10.1093/narcan/zcaf039}
}
EUVIMED